0001592052-13-000002.txt : 20131203 0001592052-13-000002.hdr.sgml : 20131203 20131203112706 ACCESSION NUMBER: 0001592052-13-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131203 DATE AS OF CHANGE: 20131203 EFFECTIVENESS DATE: 20131203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Centrexion Corp CENTRAL INDEX KEY: 0001592052 IRS NUMBER: 320402377 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-207282 FILM NUMBER: 131253613 BUSINESS ADDRESS: STREET 1: 509 S. EXETER ST., SUITE 202 CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 212-956-1111 MAIL ADDRESS: STREET 1: 509 S. EXETER ST., SUITE 202 CITY: BALTIMORE STATE: MD ZIP: 21202 D 1 primary_doc.xml X0707 D LIVE 0001592052 Centrexion Corp 509 S. EXETER ST., SUITE 202 BALTIMORE MD MARYLAND 21202 410-522-8701 DELAWARE None None Corporation true 2013 Sol Barer c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Director Isaac Blech c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Director Kerrie L. Brady c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Executive Officer James N. Campbell c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Executive Officer Director Jeffrey B. Kindler c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Executive Officer Arnold L. Oronsky c/o Centrexion Corporation 509 S. Exeter St., Suite 202 Baltimore MD MARYLAND 21202 Director Biotechnology Decline to Disclose 06b false 2013-11-20 false true true Series A Convertible Preferred Stock true 5,000,000 shares issued in connection with a merger and an asset purchase. 0 8750000 8750000 0 Series A Convertible Preferred Stock issued as consideration in a merger transaction and an asset purchase transaction. false 20 0 0 0 true false Centrexion Corp /s/ Sol Barer Sol Barer Authorized Person 2013-12-03